Home  |  Contact

UniProtKB/Swiss-Prot Q15334: Variant p.Ser148Gly

Lethal(2) giant larvae protein homolog 1
Gene: LLGL1
Variant information

Variant position:  148
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Serine (S) to Glycine (G) at position 148 (S148G, p.Ser148Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  148
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1064
The length of the canonical sequence.

Location on the sequence:   DGASAPLSLTRVTVVLLVAA  S DIAALGTEGSSVFFLDVTTL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DGASAPLSLTRVTVVLLVAASDIAALGTEGSSVFFLDVTTL

Mouse                         DNASFPASLTRVTVVLLVAG-NTAALGTESGSIFFLDVATL

Rat                           GNASFPAGLTRVTVVLLAAG-DTVVLGTESGSIFFLDVATL

Bovine                        DNASFPAGLTRVTVVLLAAG-DTVVLGTESGSIFFLDVATL

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1064 Lethal(2) giant larvae protein homolog 1
Repeat 139 – 176 WD 3


Literature citations

A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain.
Strand D.J.; Unger S.; Corvi R.; Hartenstein K.; Schenkel H.; Kalmes A.; Merdes G.; Neumann B.; Kreig-Schneider F.; Coy J.F.; Poustka A.; Schwab M.; Mechler B.;
Oncogene 11:291-301(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; SUBCELLULAR LOCATION; TISSUE SPECIFICITY; INTERACTION WITH MYOSIN II HEAVY CHAIN; VARIANTS GLY-148 AND HIS-550;

The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2.
Koyama K.; Fukushima Y.; Inazawa J.; Tomotsune D.; Takahashi N.; Nakamura Y.;
Cytogenet. Cell Genet. 72:78-82(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT GLY-148;

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT GLY-148;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.